Acasti Pharma | ACST - Gross Profit On Sales


Acasti Pharma reported $0 in Gross Profit on Sales for its fiscal quarter ending in March of 2022.





Gross Profit On Sales Change Date
Acasti Pharma USD 0 0 Mar/2022
Addus HomeCare USD 123.6M 6.89M Dec/2025
Amarin USD 22.21M 28.15M Sep/2025
Cassava Sciences USD -3.96M 1.16M Sep/2025
Knight Therapeutics CAD 55.81M 10.98M Sep/2025
Option Care Health USD 282.9M 10M Dec/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Tilray USD 67.63M 15.62M Mar/2025